Impact of a new generation of gene transfer markers on gene therapy
暂无分享,去创建一个
[1] A. Zander,et al. Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene. , 1997, Human gene therapy.
[2] C. Eaves,et al. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. , 1997, Human gene therapy.
[3] C. Bordignon,et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.
[4] H. Heslop,et al. Measuring gene–transfer efficiency , 1996, Nature Medicine.
[5] E. Gilboa,et al. Cell–surface markers for assessing gene transfer into human hematopoietic cells , 1996, Nature Medicine.
[6] S. Chevalier,et al. Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. , 1996, Blood.